<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="pediatricmusic/PMC6213542/results/search/drugs/results.xml">
  <result pre="cells, production and release of inflammatory cytokines, chemokines, proteases, and" exact="nitric oxide" post="that induce the production of proapoptotic lipid ceramide ["/>
  <result pre="or placebo. After 26 weeks of treatment, patients in the" exact="laronidase" post="group showed improved forced vital capacity and walking distance,"/>
  <result pre="S. et al. MPS VI Study Group. The effect of" exact="galsulfase" post="enzyme replacement therapy on the growth of patients with"/>
  <result pre="al. Safety and physiological effects of two different doses of" exact="elosulfase alfa" post="in patients with morquio a syndrome: A randomized, double-blind,"/>
  <result pre="Berger K.I. Jester A. Treadwell M. et al. Impact of" exact="elosulfase alfa" post="in patients with morquio A syndrome who have limited"/>
  <result pre="AR b-glucuronidase DS/HS/C6S 1 + MPS IX Hyaluronidase deficiency AR" exact="hyaluronidase" post="deficiency hyaluronidase none None (2 Families described) ± ijms-19-03063-t002_Table"/>
  <result pre="DS/HS/C6S 1 + MPS IX Hyaluronidase deficiency AR hyaluronidase deficiency" exact="hyaluronidase" post="none None (2 Families described) ± ijms-19-03063-t002_Table 2 Table"/>
 </snippets>
</snippetsTree>
